Document is current
Any future updates will be listed below
-
Authors
Yoshida, Hana
Inoda, Satoru https://orcid.org/0000-0003-4577-8169
Takahashi, Hidenori
Takahashi, Ryota
Hashimoto, Yuto
Takahashi, Hironori
Kawashima, Hidetoshi
Yanagi, Yasuo
- License Information
-
More Information
Article History
Received: 17 March 2024
Revised: 10 June 2024
Accepted: 4 July 2024
First Online: 12 July 2024
Declarations
:
: This retrospective study was approved by the institutional review board of Jichi Medical University (JICHI20-089) and adhered to the tenets of the Declaration of Helsinki. The study procedures followed institutional guidelines.
: Written informed consent was obtained from the parents.
: Hana Yoshida, Ryota Takahashi, Yuto Hashimoto, and Hironori Takahashi declare that they have no competing interest. Satoru Inoda declares lecturer’s fees from Kowa, Novartis, Bayer, Santen, Chugai, and DeepEyeVision, Inc., and grants from Novartis outside this work. Hidenori Takahashi was a founder of DeepEyeVision, Inc., and declares patents outside this work, lecturer’s fees from Santen, Kowa, Senju, Novartis, and Bayer outside this work, and grants from Senju, Novartis and Bayer outside this work. Hidetoshi Kawashima declares lecturer’s fees from Otsuka, Senju, Mitsubishi-Tanabe, Kowa, Santen, Novartis and Zeiss outside this work and grants from Senju, Linical, DeepEyeVision, HOYA, Santen, Heiwa-Iyou, and Bayer outside this work. Yasuo Yanagi declares grants from Santen and Novartis outside this work.
